Published in:
01-10-2007 | Abstracts
Poster Presentations
Authors:
M. O. Bittencourt, M. F. Dias, P. M. Le Figueiredo, N. R. Souza
Published in:
Drug Safety
|
Issue 10/2007
Login to get access
Excerpt
Background: Brazilian Medicine Monitoring Centre (CNMM) was created in May 2001, and was accepted as the 62nd official member of WHO Programme for International Drug Monitoring, although pharmacovigilance activities started at 1999. CNMM is held in Pharmacovigilance Office, in Brazilian Health Surveillance Agency (Anvisa). Since its creation, CNMM has adopted four guidelines for drug monitoring: safety, effectiveness, quality deviations and rational drug use. …